Imfinzi (durvalumab) - AstraZeneca
Keytruda (pembrolizumab) - Merck (MSD)
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
AiRuiKa (camrelizumab) - Elevar Therapeutics
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology
Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly
https://cattendee.abstractsonline.com/meeting/21487/presentation/2465
 
J. Shi; J. Shi; H. Liu; S. Li; X. Li
 
Jul 31, 2026
 
Prev Next